Resistance to Chemotherapy in Uterine Cancer: Mechanisms and Current therapies for Systemic treatment of Gynaecologic Malignancies
Received Date: Aug 01, 2023 / Published Date: Aug 30, 2023
Abstract
Uterine cancer, also known as endometrial cancer, is a type of cancer that originates in the lining of the uterus, called the endometrium. It is one of the most common gynecological cancers among women, primarily affecting those who have reached or are approaching menopause. Uterine cancer develops when the cells in the endometrium begin to grow uncontrollably, forming a tumor. This type of cancer can present various symptoms, such as abnormal vaginal bleeding (including post-menopausal bleeding), pelvic pain, and unusual vaginal discharge. While the exact cause of uterine cancer is not always clear, several risk factors, including hormonal imbalances, obesity, a family history of uterine or colon cancer, and certain medical conditions like polycystic ovary syndrome (PCOS), may increase the likelihood of its development.
Citation: Gustavo R (2023) Resistance to Chemotherapy in Uterine Cancer: Mechanisms and Current therapies for Systemic treatment of Gynaecologic Malignancies. Current Trends Gynecol Oncol, 8: 167. Doi: 10.4172/ctgo.1000167
Copyright: © 2023 Gustavo R. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 343
- [From(publication date): 0-2023 - Nov 13, 2024]
- Breakdown by view type
- HTML page views: 287
- PDF downloads: 56